Curare
Curare is a common name for various alkaloid arrow poisons originating from plant extracts. Used as a paralyzing agent by indigenous peoples in Central and South America for hunting and for therapeutic purposes, curare only becomes active when it contaminates a wound or is introduced directly to the bloodstream; it is not active when ingested orally.
Curare is prepared by boiling the bark of one of the dozens of plant sources, leaving a dark, heavy paste that can be applied to arrow or dart heads.
These poisons cause weakness of the skeletal muscles and, when administered in a sufficient dose, eventual death by asphyxiation due to paralysis of the diaphragm. In medicine, curare has been used as a treatment for tetanus and strychnine poisoning and as a paralyzing agent for surgical procedures.
History
The word 'curare' is derived from wurari, from the Carib language of the Macusi of Guyana. It has its origins in the Carib phrase "mawa cure" meaning of the Mawa vine, scientifically known as Strychnos toxifera. Curare is also known among indigenous peoples as ampi, woorari, woorara, woorali, wourali, wouralia, ourare, ourari, urare, urari, and uirary. The region throughout which curare has been used is a wide zone covering parts of the Amazon. The noun 'curare' is not to be confused with the Latin verb 'curare'.Classification
In 1895, pharmacologist Rudolf Boehm sought to classify the various alkaloid poisons based on the containers used for their preparation. He believed curare could be categorized into three main types as seen below. However useful it appeared, it became rapidly outmoded. Richard Gill, a plant collector, found that the indigenous peoples began to use a variety of containers for their curare preparations, henceforth invalidating Boehm's basis of classification.- Tube or bamboo curare: Mainly composed of the toxin D-tubocurarine, this poison is found packed into hollow bamboo tubes. Tube curare is derived from Chondrodendron and other genera in the Menispermaceae. According to their LD50 values, tube curare is thought to be the most toxic.
- Pot curare: Mainly composed of alkaloid components protocurarine, protocurine, and protocuridine from both Menispermaceae and Loganiaceae/Strychnaceae. This subtype was originally found packed in terra cotta pots.
- Calabash or gourd curare: Mainly composed of CtoxiferineI, this poison, derived from Loganiaceae/Strychnaceae alone, was originally packed into hollow gourds.
The results of the early work were very inaccurate because of the complexity and variation of the composition of the mixtures of alkaloids involved these were impure, non-crystalline alkaloids Almost all curare preparations were and are complex mixtures, and many of the physiological actions attributed to the early curarizing preparations were undoubtedly due to impurities, particularly to other alkaloids present. The curare preparations are now considered to be of two main types, those from Chondrodendron or other members of the Menispermaceae family and those from Strychnos, a genus of the Loganiaceae family. Some preparations may contain alkaloids from both and the majority have other secondary ingredients.
Hunting uses
Curare was used as a paralyzing poison by many South American indigenous people. Since it was too expensive to be used in warfare, curare was mainly used for hunting. The prey was shot by arrows or blowgun darts dipped in curare, leading to asphyxiation owing to the inability of the victim's respiratory muscles to contract. In particular, the poison was used by the Kalinago, indigenous people of the Lesser Antilles in the Caribbean, on the tips of their arrows. In addition, the Yagua people, indigenous to Colombia and northeastern Peru, commonly used these toxins via blowpipes to target prey 30 to 40 paces distant.Due to its popularity among the indigenous people as means of paralyzing prey, certain tribes would create monopolies from curare production. Thus, curare became a symbol of wealth among the indigenous populations.
In 1596, Sir Walter Raleigh mentioned the arrow poison in his book Discovery of the Large, Rich, and Beautiful Empire of Guiana, though the poison he described was possibly not curare. In 1780, Abbe Felix Fontana discovered that it acted on the voluntary muscles rather than the nerves and the heart. In 1832, Alexander von Humboldt gave the first western account of how the toxin was prepared from plants by Orinoco River natives.During 1811–1812, Sir Benjamin Collins Brody experimented with curare. He was the first to show that curare does not kill the animal and the recovery is complete if the animal's respiration is maintained artificially. In 1825, Charles Waterton described a classical experiment in which he kept a curarized female donkey alive by artificial respiration with a bellows through a tracheostomy. Waterton is also credited with bringing curare to Europe. Robert Hermann Schomburgk, who was a trained botanist, identified the vine as one of the genus Strychnos and gave it the now accepted name Strychnos toxifera.
Medical use
showed in 1850 that curare was effective for the treatment of tetanus and strychnine poisoning. In 1857, Claude Bernard published the results of his experiments in which he demonstrated that the mechanism of action of curare was a result of interference in the conduction of nerve impulses from the motor nerve to the skeletal muscle, and that this interference occurred at the neuromuscular junction. From 1887, the Burroughs Wellcome catalogue listed under its 'Tabloids' brand name, grain tablets of curare for use in preparing a solution for hypodermic injection. In 1914, Henry Hallett Dale described the physiological actions of acetylcholine. After 25 years, he showed that acetylcholine is responsible for neuromuscular transmission, which can be blocked by curare.The best known and historically most important toxin is d-tubocurarine. It was isolated from the crude drug – from a museum sample of curare – in 1935 by Harold King of London, working in Sir Henry Dale's laboratory. King also established its chemical structure. Pascual Scannone, a Venezuelan anesthesiologist who trained and specialized in New York City, did extensive research on curare as a possible paralyzing agent for patients during surgical procedures. In 1942, he became the first person in Latin America to use curare during a medical procedure when he successfully performed a tracheal intubation in a patient to whom he administered curare for muscle paralysis at the El Algodonal Hospital in Caracas, Venezuela.After its introduction in 1942, curare/curare-derivatives became a widely used paralyzing agent during medical and surgical procedures. Later, it has been superseded by a number of synthetic curare-like agents, such as pancuronium, which have a similar pharmacodynamic profile, but fewer side effects.
Chemical structure
The various components of curare are organic compounds classified as either isoquinoline or indole alkaloids. Tubocurarine is one of the major active components in the South American dart poison. As an alkaloid, tubocurarine is a naturally occurring compound that consists of nitrogenous bases, although the chemical structure of alkaloids is highly variable.Tubocurarine and C toxiferine consist of a cyclic system with quaternary ammonium ions. On the other hand, while acetylcholine does not contain a cyclic system, it does contain a quaternary ammonium ion. Because of this shared moiety, curare alkaloids can bind readily to the active site of receptors for acetylcholine at the neuromuscular junction, blocking nerve impulses from being sent to the skeletal muscles, effectively paralyzing the muscles of the body.
Pharmacological properties
Curare is an example of a non-depolarizing muscle relaxant that blocks the nicotinic acetylcholine receptor, one of the two types of acetylcholine receptors, at the neuromuscular junction. The main toxin of curare, d-tubocurarine, occupies the same position on the receptor as ACh with an equal or greater affinity, and elicits no response, making it a competitive antagonist. The antidote for curare poisoning is an acetylcholinesterase inhibitor, such as physostigmine or neostigmine. By blocking ACh degradation, AChE inhibitors raise the amount of ACh in the neuromuscular junction; the accumulated ACh will then correct for the effect of the curare by activating the receptors not blocked by toxin at a higher rate.The time of onset varies from within one minute, to between 15 and 25 minutes.
It is harmless if taken orally because curare compounds are too large and highly charged to pass through the lining of the digestive tract to be absorbed into the blood. For this reason, people can safely eat curare-poisoned prey, and it has no effect on its flavor.
Anesthesia
Isolated attempts to use curare during anesthesia date back to 1912 by Arthur Lawen of Leipzig, but curare came to anesthesia via psychiatry. In 1939 Abram Elting Bennett used it to modify metrazol induced convulsive therapy. Muscle relaxants are used in modern anesthesia for many reasons, such as providing optimal operating conditions and facilitating intubation of the trachea. Before muscle relaxants, anesthesiologists needed to use larger doses of the anesthetic agent, such as ether, chloroform or cyclopropane to achieve these aims. Such deep anesthesia risked killing patients who were elderly or had heart conditions.The source of curare in the Amazon was first researched by Richard Evans Schultes in 1941. Since the 1930s, it was being used in hospitals as a muscle relaxant. He discovered that different types of curare called for as many as 15 ingredients, and in time helped to identify more than 70 species that produced the drug.
In the 1940s, it was used on a few occasions during surgery as it was mistakenly thought to be an analgesic or anesthetic. The patients reported feeling the full intensity of the pain though they were not able to do anything about it since they were essentially paralyzed.
On January 23, 1942, Harold Griffith and Enid Johnson gave a synthetic preparation of curare to a patient undergoing an appendectomy. Safer curare derivatives, such as rocuronium and pancuronium, have superseded d-tubocurarine for anesthesia during surgery. When used with halothane d-tubocurarine can cause a profound fall in blood pressure in some patients as both the drugs are ganglion blockers. However, it is safer to use d-tubocurarine with ether.
In 1954, an article was published by Beecher and Todd suggesting that the use of muscle relaxants increased death due to anesthesia nearly sixfold. This was refuted in 1956.
Modern anesthetists have at their disposal a variety of muscle relaxants for use in anesthesia. The ability to produce muscle relaxation irrespective of sedation has permitted anesthetists to adjust the two effects independently and on the fly to ensure that their patients are safely unconscious and sufficiently relaxed to permit surgery. The use of neuromuscular blocking drugs carries with it the risk of anesthesia awareness.